文献速递胸部CT

COPD与吸烟者正常表现肺组织异质性相似,并可预测COPD的疾病负担与进展

Heterogeneity in Normal-Appearing Lung Tissue is Similar Between COPD and Smokers, and Predicts Morbidity and Progression in COPD.
PubMed 文献 · Acad Radiol · 2025-08-26

研究分析COPDGene队列520名参与者吸气相CT,用四叉树分解量化正常表现肺组织异质性,发现中密度组织异质性在无气流阻塞的当前/既往吸烟者与COPD间相似且均高于从不吸烟者,校正肺气肿等后异质性独立关联FEV1%预计值、SGRQ评分、mMRC呼吸困难评分、六分钟步行距离及随访FEV1下降。

要点

  • 中密度(-900至-750 HU)组织异质性在吸烟者与COPD间无显著差异,但均高于从不吸烟者。
  • 正常表现肺组织异质性独立关联FEV1%预计值、SGRQ、mMRC、六分钟步行距离及FEV1下降。
  • 提示需关注吸烟者及COPD患者正常表现肺组织的早期细微结构改变。

核心结论

  • 正常表现肺组织异质性与COPD呼吸疾病负担及疾病进展相关。
  • 中密度组织异质性在无气流阻塞的当前和既往吸烟者与COPD间相似(0.15±0.05 cf. 0.16±0.06,p=0.11),且显著高于从不吸烟者(0.10±0.03,p<0.001)。

研究设计与样本

  • 分析COPDGene研究中520名参与者,包括从不吸烟者、无气流阻塞的当前和既往吸烟者及COPD(GOLD1-4)。
  • 采用四叉树分解从吸气相CT提取中密度(-900至-750 HU)、低密度(< -900 HU)及全部组织合并的空间连续异质性指标。
  • 使用多变量回归检验异质性与肺功能及呼吸疾病负担的关联。

诊断标准与关键数值

  • 中密度组织异质性:当前和既往吸烟者无气流阻塞者0.15±0.05,COPD 0.16±0.06,两者比较p=0.11;从不吸烟者0.10±0.03,与上述两组比较p<0.001。
  • 校正肺气肿、年龄、性别、种族、吸烟状态和BMI后,异质性独立关联FEV1%预计值、圣乔治呼吸问卷评分、改良医学研究委员会呼吸困难评分、六分钟步行距离及随访时更大的FEV1下降。

临床应用与阅片要点

  • 阅片时可关注正常表现肺组织的中密度(-900至-750 HU)区域空间异质性,其改变在吸烟者及COPD患者中均可见。
  • 异质性指标独立于肺气肿等指标关联呼吸疾病负担和FEV1下降,提示报告时可留意正常表现肺组织的细微结构改变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Studies have identified important associations between computed tomography (CT) features of the normal-appearing lung tissue and patient outcomes, however, the heterogeneity of normal-appearing tissue has not previously been considered in chronic obstructive pulmonary disease (COPD).

METHODS: We aimed to quantify heterogeneity in normal-appearing lung tissue on inspiratory CT imaging and its relationship with lung function and clinical outcomes. We analysed data from 520 participants enroled in the COPDGene study, including never-smokers, current and former smokers without airflow obstruction, and COPD (GOLD1-4). Quadtree decomposition was used to derive spatially-connected heterogeneity metrics for medium (-900 to -750 HU) and low (< -900 HU) density tissues, and for all tissues combined. Medium density included tissue typically classified as normal-appearing by HU thresholding. Associations between heterogeneity, lung function, and respiratory morbidity were tested using multivariable regression.

RESULTS: Heterogeneity in medium-density tissue was similar between current and former smokers without airflow obstruction and COPD (0.15±0.05 cf. 0.16±0.06, p=0.11), and was significantly higher than in never-smokers (0.10±0.03, p<0.001). After adjusting for emphysema, age, sex, race, smoking status, and BMI, heterogeneity was independently associated with FEV1 % predicted, St. George's Respiratory Questionnaire score, modified Medical Research Council dyspnoea score, six-minute walk distance, and greater FEV1 decline at follow-up.

CONCLUSION: Heterogeneity of normal-appearing lung tissue is associated with respiratory morbidity and disease progression in COPD. This highlights the importance of detecting subtle early changes in tissue architecture in current and former smokers at risk for and with COPD.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. John J, Burrowes KS, Bhatt SP, et al. Heterogeneity in Normal-Appearing Lung Tissue is Similar Between COPD and Smokers, and Predicts Morbidity and Progression in COPD. Acad Radiol. 2025. PMID: 40866276. doi:10.1016/j.acra.2025.08.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。